{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:17:40Z","timestamp":1791285460721,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00431-021-04333-3","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T19:05:58Z","timestamp":1641409558000},"page":"1465-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Blood pressure and glomerular filtration rate in youth with tuberous sclerosis complex"],"prefix":"10.1007","volume":"181","author":[{"given":"Efthymia","family":"Vargiami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9843-8198","authenticated-orcid":false,"given":"Stella","family":"Stabouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Sidira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kyriazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Notopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Zafeiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"4333_CR1","doi-asserted-by":"publisher","unstructured":"Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Annals of the New York Academy of Sciences 615:125\u2013127. https:\/\/doi.org\/10.1111\/j.1749-6632.1991.tb37754.x","DOI":"10.1111\/j.1749-6632.1991.tb37754.x"},{"key":"4333_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805\u2013808. https:\/\/doi.org\/10.1126\/science.277.5327.805","journal-title":"Science"},{"key":"4333_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ng0992-37","volume":"2","author":"RS Kandt","year":"1992","unstructured":"Kandt RS, Haines JL, Smith M et al (1992) Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37\u201341. https:\/\/doi.org\/10.1038\/ng0992-37","journal-title":"Nat Genet"},{"key":"4333_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305\u20131315. https:\/\/doi.org\/10.1016\/0092-8674(93)90618-Z","journal-title":"Cell"},{"key":"4333_CR5","doi-asserted-by":"publisher","unstructured":"Henske EP, J\u00f3zwiak S, Kingswood JC et al (2016) Tuberous sclerosis complex. Nature Reviews Disease Primers 2. https:\/\/doi.org\/10.1038\/nrdp.2016.35","DOI":"10.1038\/nrdp.2016.35"},{"key":"4333_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/dmcn.13352","volume":"59","author":"S Amin","year":"2017","unstructured":"Amin S, Lux A, Calder N et al (2017) Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol 59:612\u2013617. https:\/\/doi.org\/10.1111\/dmcn.13352","journal-title":"Dev Med Child Neurol"},{"key":"4333_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66:792\u2013796. https:\/\/doi.org\/10.1016\/S0025-6196(12)61196-3","journal-title":"Mayo Clin Proc"},{"key":"4333_CR8","doi-asserted-by":"publisher","unstructured":"Eijkemans MJC, van der Wal W, Reijnders LJ et al (2015) Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am J Kidney Dis 66. https:\/\/doi.org\/10.1053\/j.ajkd.2015.05.016","DOI":"10.1053\/j.ajkd.2015.05.016"},{"key":"4333_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajmg.c.31654","volume":"178","author":"JJ Bissler","year":"2018","unstructured":"Bissler JJ, Christopher Kingswood J (2018) Renal manifestation of tuberous sclerosis complex. Am J Med Genet C Semin Med Genet 178:338\u2013347. https:\/\/doi.org\/10.1002\/ajmg.c.31654","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"4333_CR10","doi-asserted-by":"publisher","unstructured":"Robertson FM, Cendron M, Klauber GT, Harris BH (1996) Renal cell carcinoma in association with tuberous sclerosis in children. J Pediatr Surg 31. https:\/\/doi.org\/10.1016\/S0022-3468(96)90689-2","DOI":"10.1016\/S0022-3468(96)90689-2"},{"key":"4333_CR11","doi-asserted-by":"publisher","unstructured":"Sauter M, Belousova E, Benedik MP et al (2021) Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet J Rare Dis 16. https:\/\/doi.org\/10.1186\/s13023-021-01917-y","DOI":"10.1186\/s13023-021-01917-y"},{"key":"4333_CR12","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00467-018-4003-6","volume":"33","author":"P Janssens","year":"2018","unstructured":"Janssens P, van Hoeve K, de Waele L et al (2018) Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study. Pediatr Nephrol 33:2085\u20132093. https:\/\/doi.org\/10.1007\/s00467-018-4003-6","journal-title":"Pediatr Nephrol"},{"key":"4333_CR13","doi-asserted-by":"publisher","unstructured":"Stevens PE (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"4333_CR14","doi-asserted-by":"publisher","unstructured":"Simonsen JA, Thilsing-Hansen K, H\u00f8ilund-Carlsen PF et al (2020) Glomerular filtration rate: comparison of simultaneous plasma clearance of 99mTc-DTPA and 51Cr-EDTA revisited. Scand J Clin Lab Invest 80. https:\/\/doi.org\/10.1080\/00365513.2020.1759138","DOI":"10.1080\/00365513.2020.1759138"},{"key":"4333_CR15","doi-asserted-by":"publisher","unstructured":"Andersen TB, J\u00f8dal L, Nielsen NS, Petersen LJ (2019) Comparison of simultaneous plasma clearance of 99mTc-DTPA and 51Cr-EDTA: can one tracer replace the other? Scand J Clin Lab Invest 79. https:\/\/doi.org\/10.1080\/00365513.2019.1658217","DOI":"10.1080\/00365513.2019.1658217"},{"key":"4333_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259\u2013263","journal-title":"Pediatrics"},{"key":"4333_CR17","first-page":"391","volume":"10","author":"M Jaffe","year":"1886","unstructured":"Jaffe M (1886) Ueber den Niederschlag, welchen Pikrins\u00e4ure in normalem Harn erzeugt und \u00fcber eine neue Reaction des Kreatinins. ZPhysiolChem 10:391\u2013400","journal-title":"ZPhysiolChem"},{"key":"4333_CR18","doi-asserted-by":"publisher","unstructured":"Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW (2012) Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8. https:\/\/doi.org\/10.1038\/nrneph.2012.19","DOI":"10.1038\/nrneph.2012.19"},{"key":"4333_CR19","doi-asserted-by":"publisher","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hyperten 34. https:\/\/doi.org\/10.1097\/HJH.0000000000001039","DOI":"10.1097\/HJH.0000000000001039"},{"key":"4333_CR20","doi-asserted-by":"publisher","unstructured":"Stabouli S, Papakatsika S, Kotronis G et al (2015) Arterial stiffness and SBP variability in children and adolescents. J Hyperten 33. https:\/\/doi.org\/10.1097\/HJH.0000000000000369","DOI":"10.1097\/HJH.0000000000000369"},{"key":"4333_CR21","doi-asserted-by":"publisher","unstructured":"Kotsis V, Stabouli S, Pitiriga V et al (2006) Ambulatory blood pressure monitoring and target organ damage: effects of age and sex. Blood Press Monit 11. https:\/\/doi.org\/10.1097\/01.mbp.0000189785.59994.20","DOI":"10.1097\/01.mbp.0000189785.59994.20"},{"key":"4333_CR22","doi-asserted-by":"publisher","unstructured":"Kollios K, Nika T, Kotsis V et al (2021) Arterial stiffness in children and adolescents with masked and sustained hypertension. J Hum Hyperten 35. https:\/\/doi.org\/10.1038\/s41371-020-0318-4","DOI":"10.1038\/s41371-020-0318-4"},{"key":"4333_CR23","doi-asserted-by":"publisher","unstructured":"Flynn JT, Daniels SR, Hayman LL et al (2014) Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents. Hypertension 63. https:\/\/doi.org\/10.1161\/HYP.0000000000000007","DOI":"10.1161\/HYP.0000000000000007"},{"key":"4333_CR24","doi-asserted-by":"publisher","unstructured":"Wassertheurer S, Kropf J, Weber T et al (2010) A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hyperten 24. https:\/\/doi.org\/10.1038\/jhh.2010.27","DOI":"10.1038\/jhh.2010.27"},{"key":"4333_CR25","doi-asserted-by":"publisher","unstructured":"Shiraishi M, Murakami T, Higashi K (2020) The accuracy of central blood pressure obtained by oscillometric noninvasive method using Mobil-O-Graph in children and adolescents. J Hyperten 38. https:\/\/doi.org\/10.1097\/HJH.0000000000002360","DOI":"10.1097\/HJH.0000000000002360"},{"key":"4333_CR26","doi-asserted-by":"publisher","unstructured":"Elmenhorst J, Hulpke-Wette M, Barta C et al (2015) Percentiles for central blood pressure and pulse wave velocity in children and adolescents recorded with an oscillometric device. Atherosclerosis 238. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.11.005","DOI":"10.1016\/j.atherosclerosis.2014.11.005"},{"key":"4333_CR27","doi-asserted-by":"publisher","unstructured":"Vekeman F, Magestro M, Karner P et al (2015) Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ 18. https:\/\/doi.org\/10.3111\/13696998.2015.1075995","DOI":"10.3111\/13696998.2015.1075995"},{"key":"4333_CR28","doi-asserted-by":"publisher","unstructured":"Kingswood JC, Nasuti P, Patel K et al (2016) The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD). J Med Econ 19. https:\/\/doi.org\/10.1080\/13696998.2016.1202254","DOI":"10.1080\/13696998.2016.1202254"},{"key":"4333_CR29","doi-asserted-by":"publisher","unstructured":"Kingswood JC, Belousova E, Benedik MP et al (2020) Renal manifestations of tuberous sclerosis complex: key findings from the final analysis of the TOSCA study focussing mainly on renal angiomyolipomas. Front Neurol 11. https:\/\/doi.org\/10.3389\/fneur.2020.00972","DOI":"10.3389\/fneur.2020.00972"},{"key":"4333_CR30","doi-asserted-by":"publisher","unstructured":"Malaga-Dieguez L, Spencer R, Pehrson LJ et al (2017) Early manifestations of renal disease in patients with tuberous sclerosis complex. Int J Nephrol Renov Dis 10. https:\/\/doi.org\/10.2147\/IJNRD.S123638","DOI":"10.2147\/IJNRD.S123638"},{"key":"4333_CR31","doi-asserted-by":"publisher","unstructured":"Pan X, Yang C, Ma S et al (2021) A case of TSC2\u2010PKD1 contiguous deletion syndrome: clinical features and effective treatment for epilepsy. Int J Dev Neurosci. https:\/\/doi.org\/10.1002\/jdn.10088","DOI":"10.1002\/jdn.10088"},{"key":"4333_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter PT, Peral B, Ward CJ et al (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2014 a contiguous gene syndrome. Nat Genet 8:328\u2013332. https:\/\/doi.org\/10.1038\/ng1294-328","journal-title":"Nat Genet"},{"key":"4333_CR33","doi-asserted-by":"publisher","unstructured":"Sampson JR, Maheshwar MM, Aspinwall R et al (1997) Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61. https:\/\/doi.org\/10.1086\/514888","DOI":"10.1086\/514888"},{"key":"4333_CR34","doi-asserted-by":"publisher","unstructured":"Sperandio M, Weber L, Jauch A et al (2000) Cutaneous white spots in a child with polycystic kidneys: a clue to TSC2\/PKD1 gene mutation. Nephrol Dial Transplant 15. https:\/\/doi.org\/10.1093\/ndt\/15.6.909","DOI":"10.1093\/ndt\/15.6.909"},{"key":"4333_CR35","doi-asserted-by":"publisher","unstructured":"Laass MW, Spiegel M, Jauch A et al (2004) Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant. Pediatr Nephrol 19. https:\/\/doi.org\/10.1007\/s00467-004-1442-z","DOI":"10.1007\/s00467-004-1442-z"},{"key":"4333_CR36","doi-asserted-by":"publisher","unstructured":"el Aoud S, Frikha F, Snoussi M et al (2017) Tuberous sclerosis complex (Bourneville-Pringle disease) in a 25-year-old female with bilateral renal angiomyolipoma and secondary hypertension. Saudi J Kidney Dis Transpl 28. https:\/\/doi.org\/10.4103\/1319-2442.206461","DOI":"10.4103\/1319-2442.206461"},{"key":"4333_CR37","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/HJH.0000000000001423","volume":"35","author":"PA Sarafidis","year":"2017","unstructured":"Sarafidis PA, Bikos A, Loutradis C et al (2017) Diagnosis of tuberous sclerosis complex in a patient referred for uncontrolled hypertension and renal dysfunction: a case highlighting the importance of proper diagnostic work-up of hypertensive patients. J Hypertens 35:2109\u20132114. https:\/\/doi.org\/10.1097\/HJH.0000000000001423","journal-title":"J Hypertens"},{"key":"4333_CR38","first-page":"253","volume":"4","author":"H Emad Momtaz","year":"2010","unstructured":"Emad Momtaz H (2010) Tuberous sclerosis with hypertension and abdominal pain in a child. Iran J Kidney Dis 4:253\u2013258","journal-title":"Iran J Kidney Dis"},{"key":"4333_CR39","doi-asserted-by":"publisher","unstructured":"Wong H, Hadi M, Khoury T et al (2006) Management of severe hypertension in a child with tuberous sclerosis-related major vascular abnormalities. J Hyperten 24. https:\/\/doi.org\/10.1097\/01.hjh.0000209994.33680.11","DOI":"10.1097\/01.hjh.0000209994.33680.11"},{"key":"4333_CR40","doi-asserted-by":"publisher","unstructured":"Nass RD, Hampel KG, Elger CE, Surges R (2019) Blood pressure in seizures and epilepsy. Front Neurol 10. https:\/\/doi.org\/10.3389\/fneur.2019.00501","DOI":"10.3389\/fneur.2019.00501"},{"key":"4333_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000448293","volume":"134","author":"JC Kingswood","year":"2016","unstructured":"Kingswood JC, Bissler JJ, Budde K et al (2016) Review of the tuberous sclerosis renal guidelines from the 2012 Consensus Conference: current data and future study. Nephron 134:51\u201358. https:\/\/doi.org\/10.1159\/000448293","journal-title":"Nephron"},{"key":"4333_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.juro.2016.09.082","volume":"197","author":"JC Warncke","year":"2017","unstructured":"Warncke JC, Brodie KE, Grantham EC et al (2017) Pediatric renal angiomyolipomas in tuberous sclerosis complex. J Urol 197:500\u2013506. https:\/\/doi.org\/10.1016\/j.juro.2016.09.082","journal-title":"J Urol"},{"key":"4333_CR43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet 381:817\u2013824. https:\/\/doi.org\/10.1016\/S0140-6736(12)61767-X","journal-title":"The Lancet"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-04333-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:13:55Z","timestamp":1648545235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-04333-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4333"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-04333-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-444696\/v1","asserted-by":"object"}]},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Aristotle University of Thessaloniki and was conducted in accordance with the 1964 Helsinki Declaration standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the parents of all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors have read and approved the paper and have met the criteria for authorship as established by the International Committee of Medical Journals Editors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DZ has received honoraria, travel and research grants from Novartis and Pharmaten. EV has received travel grants from Novartis. SS, CS, MK, AA and AN declare that they have no financial interests. DZ has served on advisory boards for Novartis and Pharmaten. EV, SS, CS, MK, AA and AN declare that they have no non-financial interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}